{
  "parse": {
    "title": "Rs429358",
    "pageid": 1775,
    "categories": [
      {
        "sortkey": "",
        "*": "Is_a_snp"
      },
      {
        "sortkey": "",
        "*": "In_dbSNP"
      },
      {
        "sortkey": "",
        "*": "SNPs_on_chromosome_19"
      },
      {
        "sortkey": "",
        "*": "Has_genotype"
      },
      {
        "sortkey": "",
        "*": "Has_population"
      },
      {
        "sortkey": "",
        "*": "Uses_omim"
      },
      {
        "sortkey": "",
        "*": "On_chip_23andMe_v3"
      },
      {
        "sortkey": "",
        "*": "On_chip_23andMe_v4"
      },
      {
        "sortkey": "",
        "*": "On_chip_23andMe_v5"
      },
      {
        "sortkey": "",
        "*": "On_chip_Ancestry_v2c"
      },
      {
        "sortkey": "",
        "*": "On_chip_Ancestry_v2d"
      },
      {
        "sortkey": "",
        "*": "On_chip_Ancestry_v2"
      },
      {
        "sortkey": "",
        "*": "On_chip_HumanOmni1Quad"
      }
    ],
    "wikitext": {
      "*": "{{Rsnum\n|rsid=429358\n|Gene=APOE\n|Chromosome=19\n|position=44908684\n|Orientation=plus\n|ReferenceAllele=T\n|MissenseAllele=C\n|GMAF=0.1492\n|Assembly=GRCh38\n|GenomeBuild=38.1\n|dbSNPBuild=141\n|geno1=(C;C)\n|geno2=(C;T)\n|geno3=(T;T)\n|Gene_s=APOE\n|StabilizedOrientation=plus\n}}{{ population diversity\n| geno1=(C;C)\n| geno2=(C;T)\n| geno3=(T;T)\n| CEU | 0.0 | 0.0 | 0.0\n| HCB | 0.0 | 0.0 | 100.0\n| JPT | 0.0 | 2.3 | 97.7\n| YRI | 0.0 | 3.2 | 96.8\n| ASW | 0.0 | 0.0 | 0.0\n| CHB | 0.0 | 0.0 | 100.0\n| CHD | 0.0 | 0.0 | 0.0\n| GIH | 0.0 | 0.0 | 0.0\n| LWK | 0.0 | 0.0 | 0.0\n| MEX | 0.0 | 0.0 | 0.0\n| MKK | 0.0 | 0.0 | 0.0\n| TSI | 0.0 | 0.0 | 0.0\n| HapMapRevision=28\n}}\nThis SNP, located in the fourth exon of the [[ApoE]] gene, affects the amino acid at position 130 of the resulting protein. The more common [[rs429358]] allele is (T). If the allele is (C) and the same chromosome also harbors the [[rs7412]](C) allele, the combination is known as an [[APOE-\u03b54]] allele. The APOE-\u03b54 allele has a strong influence on the risk of [[Alzheimer's disease]]. \n\nMany studies have estimated the level of risk, and it varies depending on age, sex, ethnicity, and other factors. One meta-analysis estimated the odds ratios for homozygous [[rs429358(C;C)]] individuals compared to the more common ApoE3/ApoE3 homozygotes to be 12x for late-onset Alzheimer's and 61x for early-onset disease. {{PMID|10325447}}\n\nMeta-analyses have also supported the association between the [[APOE-\u03b54]] allele and somewhat increased risk for [[heart disease]], with an odds ratio of 1.42 (CI: 1.26 - 1.61).{{PMID| 15488874}}\n\nNote: Although [[ApoE]] status is technically defined by these two SNPs, [[rs429358]] and [[rs7412]], a SNP in the adjacent ApoC1 gene, [[rs4420638]], is co-inherited with ApoE and thus often - though not completely - predictive of it. \n\n{{omim\n|desc=HYPERLIPOPROTEINEMIA, TYPE III, AUTOSOMAL DOMINANT\n|id=107741\n|rsnum=429358\n|variant=0008\n}}\n{{omim\n|desc=ALZHEIMER DISEASE 2\n|id=107741\n|rsnum=429358\n|variant=0016\n}}\n{{omim\n| id = 107741\n| variant = 0022\n| desc    = HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE4\n| rsnum   = 429358\n}}\n\n{{omim\n|desc=STROKE, ISCHEMIC\n|id=601367\n|rsnum=429358\n}}\n{{PMID Auto\n|PMID=19818961\n|Title=Apolipoprotein E genotype is associated with serum C-reactive protein but not abdominal aortic aneurysm\n|OA=1\n}}\n\n{{PMID Auto GWAS\n|PMID=20100581\n|Trait=Brain imaging\n|Title=Whole Genome Association Study of Brain-Wide Imaging Phenotypes for Identifying Quantitative Trait Loci in MCI and AD: A Study of the ADNI Cohort\n|RiskAllele=\n|Pval=NS\n|OR=None\n|ORtxt=None\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=20406466\n|Title=Genetic variants associated with fasting blood lipids in the U.S. population: Third National Health and Nutrition Examination Survey\n|OA=1\n}}\n{{PMID Auto\n|PMID=20429872\n|Title=Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub-study\n|OA=1\n}}\n{{PMID Auto\n|PMID=20822524\n|Title=Isoform of APOE with retained intron 3; quantitation and identification of an associated single nucleotide polymorphism\n|OA=1\n}}\n{{PMID Auto\n|PMID=20946940\n|Title=Association of variants within APOE; SORL1; RUNX1; BACE1 and ALDH18A1 with dementia in Alzheimer's disease in subjects with Down syndrome\n}}\n\n{{PMID Auto\n|PMID=21263195\n|Title=An APOE Haplotype Associated with Decreased ?4 Expression Increases the Risk of Late Onset Alzheimer's Disease\n}}\n\n{{PMID Auto GWAS\n|PMID=21123754\n|Trait=None\n|Title=Genome-wide association study of CSF biomarkers A{beta}1-42, t-tau, and p-tau181p in the ADNI cohort.\n|RiskAllele=\n|Pval=0.000001\n|OR=None\n|ORtxt=None\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=22174202\n|Title=Apolipoprotein E Gene Polymorphisms Are Strong Predictors of Inflammation and Dyslipidemia in Rheumatoid Arthritis\n}}\n\n{{ClinVar\n|rsid=429358\n|Reversed=0\n|FwdREF=T\n|FwdALT=C\n|REF=T\n|ALT=C\n|RSPOS=45411941\n|CHROM=19\n|GMAF=0.1493\n|dbSNPBuildID=80\n|SSR=0\n|SAO=1\n|VP=0x050368000a05150537130100\n|GENEINFO=APOE:348\n|GENE_NAME=APOE\n|GENE_ID=348\n|WGT=1\n|VC=SNV\n|CLNALLE=1\n|CLNHGVS=NC_000019.9:g.45411941T>C\n|CLNORIGIN=1\n|CLNSIG=255\n|Tags=PM;PMC;S3D;SLO;NSM;REF;ASP;VLD;G5;HD;GNO;KGPhase1;KGPhase3;LSD;MTP;OM\n|CAF=0.8494; 0.1506\n|CLNACC=RCV000019438.29; RCV000019448.31; RCV000019455.29; RCV000019456.28; RCV000019458.24; RCV000292119.1\n|CLNDBN=Familial type 3 hyperlipoproteinemia; Alzheimer disease 2; APOE4(-)-FREIBURG; APOE4 VARIANT; not provided\n|CLNDSDB=MedGen\n|CLNDSDBID=CN221809\n|CLNSRC=OMIM Allelic Variant; UniProtKB (protein)\n|CLNSRCID=107741.0008; 107741.0016; 107741.0022; 107741.0023; 107741.0025; P02649#VAR_000652\n|COMMON=1\n|Disease=Familial type 3 hyperlipoproteinemia; Alzheimer disease 2; APOE4(-)-FREIBURG; APOE4 VARIANT; not provided\n|CLNREVSTAT=no_criteria\n}}\n\n{{PMID Auto\n|PMID=15113403\n|Title=Current limitations of SNP data from the public domain for studies of complex disorders: a test for ten candidate genes for obesity and osteoporosis.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=15157284\n|Title=Patterns of linkage disequilibrium and haplotype distribution in disease candidate genes.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=16603077\n|Title=Variation at APOE and STH loci and Alzheimer's disease.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=17048007\n|Title=Association of warfarin dose with genes involved in its action and metabolism.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=17356695\n|Title=Variation in GYS1 interacts with exercise and gender to predict cardiovascular mortality.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=17357073\n|Title=Genetic analysis of 103 candidate genes for coronary artery disease and associated phenotypes in a founder population reveals a new association between endothelin-1 and high-density lipoprotein cholesterol.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=17434289\n|Title=Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=17456829\n|Title=Evaluation of genetic factors for warfarin dose prediction.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=17672902\n|Title=Subarachnoid hemorrhage: tests of association with apolipoprotein E and elastin genes.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=17903299\n|Title=A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=18034366\n|Title=Lack of replication of genetic associations with human longevity.\n}}\n\n{{PMID Auto\n|PMID=18196181\n|Title=Correction of population stratification in large multi-ethnic association studies.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=18216863\n|Title=Genetic determinants of basal C-reactive protein expression in Filipino systemic lupus erythematosus families.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=18254975\n|Title=Physiogenomic comparison of human fat loss in response to diets restrictive of carbohydrate or fat.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=18275964\n|Title=Low-density lipoprotein and high-density lipoprotein cholesterol levels in relation to genetic polymorphisms and menopausal status: the Atherosclerosis Risk in Communities (ARIC) Study.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=18378515\n|Title=APOE/C1/C4/C2 hepatic control region polymorphism influences plasma apoE and LDL cholesterol levels.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=18448515\n|Title=Evidence that the gene encoding insulin degrading enzyme influences human lifespan.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=18513389\n|Title=New application of intelligent agents in sporadic amyotrophic lateral sclerosis identifies unexpected specific genetic background.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=18574025\n|Title=The largest prospective warfarin-treated cohort supports genetic forecasting.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=18596683\n|Title=Dosing algorithms to predict warfarin maintenance dose in Caucasians and African Americans.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=18603647\n|Title=Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=18678618\n|Title=Comprehensive association study of type 2 diabetes and related quantitative traits with 222 candidate genes.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=18823527\n|Title=A genome-wide association study for late-onset Alzheimer's disease using DNA pooling.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=18974842\n|Title=Gender differences in genetic risk profiles for cardiovascular disease.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=18976728\n|Title=Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=19001172\n|Title=Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: implication of additional loci.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=19014573\n|Title=Application of two machine learning algorithms to genetic association studies in the presence of covariates.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=19058936\n|Title=A polymorphism of apolipoprotein E (APOE) gene is associated with age at natural menopause in Caucasian females.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=19118814\n|Title=Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=19131662\n|Title=A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=19262956\n|Title=GAB2 gene does not modify the risk of Alzheimer's disease in Spanish APOE 4 carriers.\n}}\n\n{{PMID Auto\n|PMID=19263529\n|Title=Genetic risk factors in recurrent venous thromboembolism: A multilocus, population-based, prospective approach.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=19285141\n|Title=Genetic determinants of target and novelty-related event-related potentials in the auditory oddball response.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=19299407\n|Title=Replication of genetic associations with plasma lipoprotein traits in a multiethnic sample.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=19336475\n|Title=Integrated associations of genotypes with multiple blood biomarkers linked to coronary heart disease risk.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=19377787\n|Title=Association between apolipoprotein E genotype, serum lipids, and colorectal cancer in Brazilian individuals.\n}}\n\n{{PMID Auto\n|PMID=19541455\n|Title=Apolipoprotein-E gene variants associated with cardiovascular risk factors in antipsychotic recipients.\n}}\n\n{{PMID Auto\n|PMID=19667110\n|Title=Identification of genetic variants associated with response to statin therapy.\n}}\n\n{{PMID Auto\n|PMID=19668339\n|Title=Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=19734902\n|Title=Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=19756043\n|Title=A simple and efficient algorithm for genome-wide homozygosity analysis in disease.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=19787382\n|Title=Introduction to the DISRUPT postprandial database: subjects, studies and methodologies.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=19913121\n|Title=Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=19936222\n|Title=Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=19951432\n|Title=Analysis of recently identified dyslipidemia alleles reveals two loci that contribute to risk for carotid artery disease.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=20082485\n|Title=Genetic variants involved in gallstone formation and capsaicin metabolism, and the risk of gallbladder cancer in Chilean women.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=20167577\n|Title=Analysis of lipid pathway genes indicates association of sequence variation near SREBF1/TOM1L2/ATPAF2 with dementia risk.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=20396431\n|Title=Genotyping sleep disorders patients.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=20451875\n|Title=Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=20565774\n|Title=Population based allele frequencies of disease associated polymorphisms in the Personalized Medicine Research Project.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=20663622\n|Title=A susceptible haplotype within APOE gene influences BMD and intensifies the osteoporosis risk in postmenopausal women of Northwest India.\n}}\n\n{{PMID Auto\n|PMID=20682755\n|Title=A pilot study of gene/gene and gene/environment interactions in Alzheimer disease.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=20832063\n|Title=Exploring genetic determinants of plasma total cholesterol levels and their predictive value in a longitudinal study.\n}}\n\n{{PMID Auto\n|PMID=21215387\n|Title=IQ, educational attainment, memory and plasma lipids: associations with apolipoprotein E genotype in 5995 children.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=21228733\n|Title=Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=21285406\n|Title=Low-density lipoprotein cholesterol and the risk of cancer: a mendelian randomization study.\n}}\n\n{{PMID Auto\n|PMID=21324458\n|Title=Association of gene variants with lipid levels in response to fenofibrate is influenced by metabolic syndrome status.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=21379329\n|Title=Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=21418511\n|Title=Genome-wide association study identifies a single major locus contributing to survival into old age; the APOE locus revisited.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=21647738\n|Title=Genome-wide association with C-reactive protein levels in CLHNS: evidence for the CRP and HNF1A loci and their interaction with exposure to a pathogenic environment.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=21689001\n|Title=Association study between apolipoprotein E gene polymorphism and diabetic nephropathy in a Taiwanese population.\n}}\n\n{{PMID Auto\n|PMID=21703254\n|Title=APOE haplotypes are associated with human longevity in a Central Italy population: evidence for epistasis with HP 1/2 polymorphism.\n}}\n\n{{PMID Auto\n|PMID=22042884\n|Title=Association of genetic variants and incident coronary heart disease in multiethnic cohorts: the PAGE study.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=22234866\n|Title=Evidence from case-control and longitudinal studies supports associations of genetic variation in APOE, CETP, and IL6 with human longevity.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=23571587\n|Title=Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E &#1013;4,and the risk of late-onset Alzheimer disease in African Americans\n|OA=1\n}}\n\n{{PMID Auto GWAS\n  |PMID=23419831\n  |Trait=Alzheimer's disease biomarkers\n  |Title=APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study.\n  |RiskAllele=C\n  |Pval=5E-14\n  |OR=NR\n  |ORtxt=NR\n  |OA=1\n}}\n\n{{PMID Auto\n|PMID=24291031\n|Title=Association of APOE, GCPII and MMP9 polymorphisms with common diseases and lipid levels in an older adult/elderly cohort\n}}\n\n{{PMID Auto\n|PMID=22651940\n|Title=The SIRT2 polymorphism rs10410544 and risk of Alzheimer's disease in two Caucasian case-control cohorts.\n}}\n\n{{PMID Auto\n|PMID=22710912\n|Title=TOMM40, APOE, and APOC1 in primary progressive aphasia and frontotemporal dementia.\n}}\n\n{{PMID Auto\n|PMID=22898894\n|Title=Pleiotropy and allelic heterogeneity in the TOMM40-APOE genomic region related to clinical and metabolic features of hepatitis C infection.\n}}\n\n{{PMID Auto\n|PMID=22922093\n|Title=Low-density lipoprotein cholesterol and risk of gallstone disease: a Mendelian randomization study and meta-analyses.\n}}\n\n{{PMID Auto\n|PMID=23100282\n|Title=Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=23207651\n|Title=A genome-wide association study implicates the APOE locus in nonpathological cognitive ageing.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=23533563\n|Title=Novel risk factors for premature peripheral arterial occlusive disease in non-diabetic patients: a case-control study.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=25085564\n|Title=Influence of multiple\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=25098835\n|Title=Longitudinal analysis is more powerful than cross-sectional analysis in detecting genetic association with neuroimaging phenotypes\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=26043189\n|Title=Genetic determinants of quantitative traits associated with cardiovascular disease risk\n}}\n\n{{PMID Auto\n|PMID=26175754\n|Title=DNA methylation and single nucleotide variants in the brain-derived neurotrophic factor (BDNF) and oxytocin receptor (OXTR) genes are associated with anxiety/depression in older women\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=26405973\n|Title=Gene environment interaction of GALNT2 and APOE gene with hypertension in the Chinese Han Population\n}}\n\n{{PMID Auto\n|PMID=26404360\n|Title=Effects of APOE rs429358, rs7412 and GSTM1/GSTT1 Polymorphism on Plasma and Erythrocyte Antioxidant Parameters and Cognition in Old Chinese Adults\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=25545672\n|Title=Apolipoprotein E gene polymorphisms in relation to chronic periodontitis, periodontopathic bacteria, and lipid levels\n}}\n\n{{PMID Auto\n|PMID=27277494\n|Title=Identifying Multimodal Intermediate Phenotypes Between Genetic Risk Factors and Disease Status in Alzheimer's Disease.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=27585988\n|Title=Structured sparse CCA for brain imaging genetics via graph OSCAR.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=27707806\n|Title=Replication of Genome-Wide Association Study Findings of Longevity in White, African American, and Hispanic Women: The Women's Health Initiative.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=28189700\n|Title=CSF protein changes associated with hippocampal sclerosis risk gene variants highlight impact of GRN/PGRN.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=28480219\n|Title=Apolipoprotein E Genotype in Very Preterm Neonates with Intrauterine Growth Restriction: An Analysis of the German Neonatal Network Cohort.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=28983317\n|Title=Genetic Analysis of Mitochondrial Ribosomal Proteins and Cognitive Aging in Postmenopausal Women.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=29532745\n|Title=Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis.\n}}\n\n{{PMID Auto\n|PMID=31833563\n|Title=A novel multi-locus genetic risk score identifies patients with higher risk of generalized aggressive periodontitis.\n}}\n\n{{PMID Auto\n|PMID=32622117\n|Title=Trace elements and APOE polymorphisms in pregnant women and their new-borns.\n}}\n\n{{PMID Auto\n|PMID=32647408\n|Title=Association of Common Single Nucleotide Polymorphisms of Candidate Genes with Gallstone Disease: A Meta-Analysis.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=33163038\n|Title=Lack of association between genetic variants in the 19q13.32 region and CHD risk in the Algerian population: a population-based nested case-control study.\n|OA=1\n}}\n\n{{PMID Auto\n|PMID=33204816\n|Title=Haplotype architecture of the Alzheimer's risk in the APOE region via co-skewness.\n|OA=1\n}}\n{{on chip | 23andMe v3}}\n{{on chip | 23andMe v4}}\n{{on chip | 23andMe v5}}\n{{on chip | Ancestry v2c}}\n{{on chip | Ancestry v2d}}\n{{on chip | Ancestry v2}}\n{{on chip | HumanOmni1Quad}}"
    }
  }
}